Showing 3421-3430 of 5956 results for "".
- Two Shots of Pfizer, AstraZeneca COVID-19 Vaccines Effective Against Delta Variant: Studyhttps://modernod.com/news/two-shots-of-pfizer-astrazeneca-covid-19-vaccines-effective-against-delta-variant-study/2479295/A real world study conducted by Public Health England shows tha
- CORE Summarizes BCLA CLEAR Guidance for Contact Lens Practitionershttps://modernod.com/news/core-summarizes-bcla-clear-guidance-for-contact-lens-practitioners/2479297/The latest issue of
- Arnaud Lacoste Is Named Chief Scientific Officer of Aurion Biotechhttps://modernod.com/news/arnaud-lacoste-is-named-chief-scientific-officer-of-aurion-biotech/2479293/Arnaud Lacoste, MBA, PhD, has been named chief scientific officer of Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies. Arnaud will lead R&D teams based in Boston and Seattle. “Arnaud is a brilliant scientist, a strategic e
- Oyster Point Pharma Announces Collaboration with Adaptive Phage Therapeutics to Target Ophthalmic Diseaseshttps://modernod.com/news/oyster-point-pharma-announces-collaboration-with-adaptive-phage-therapeutics-to-target-ophthalmic-diseases/2479281/Oyster Point Pharma announced a newly formed research collaboration with Adaptive Phage Therapeutics (APT) to leverage APT’s PhageBank technology for the development of potential treatments for multiple ophthalmic diseases. APT’s PhageBank technology is engi
- Oxular Appoints Dr. Friedrich Asmus as Chief Medical Officerhttps://modernod.com/news/oxular-appoints-dr-friedrich-asmus-as-chief-medical-officer/2479267/Oxular Limited announced it has appointed Friedrich (Fritz) Asmus, MD, as Chief Medical Officer. Dr. Asmus will lead all medical, clinical, and regulatory functions to further the company’s lead asset, OXU‑001, for the treatment of diabetic macular edema (DME), and to accelerate the development o
- High Caffeine Consumption May Be Associated With Increased Risk of Glaucomahttps://modernod.com/news/high-caffeine-consumption-may-be-associated-with-increased-risk-of-blinding-eye-disease/2479268/Consuming large amounts of daily caffeine may increase the risk of glaucoma more than three-fold for those with a genetic predisposition to higher eye pressure, according to an international multicenter study. The research led by the Icahn School of Medicine at Mount Sinai is the first to demonst
- CooperVision Expands Leadership Teamhttps://modernod.com/news/coopervision-expands-leadership-team/2479259/CooperVision announced the hiring of Kamela Bearlin as Senior Global Brand Director, 1 Day Brands; and Jennifer Lambert as Senior Global Brand Director, Myopia Management; and promoted Elizabeth Lumb, BSc(Hons) MCOptom, FBCLA, to Director of Global Professional Affairs, Myopia Management.
- AcuFocus Appoints Industry Leader John Garland as Global Vice President of Saleshttps://modernod.com/news/acufocus-appoints-industry-leader-john-garland-as-global-vice-president-of-sales/2479257/AcuFocus announced that it has appointed John Garland as its Global Vice President of Sales. In his new role, he will be responsible for global sales strategy and will focus initially on building the US sales field team. Mr. Garland brings more than 30 years of experience to the position w
- Arctic Vision Announces Exclusive Licensing Agreement With ActualEyeshttps://modernod.com/news/arctic-vision-announces-exclusive-licensing-agreement-with-actualeyes/2479210/Arctic Vision and ActualEyes, a clinical stage Japanese biotech company committed to the research and development of cell therapy for corneal endothelial diseases, jointly announced an exclusive licensing agreement for Arctic Vision to develop and commercialize ActualEyes’ lead product cand
- Innovega’s eMacula System Shows Potential to Increase Independence for Visually Impairedhttps://modernod.com/news/innovegas-emacula-system-shows-potential-to-increase-independence-for-visually-impaired/2479190/The use of Innovega eMacula system, which pairs smart contact lenses with display eyewear, demonstrated positive results with partially sighted subjects for their daily tasks, including reading, smart phone use, and distance vision, according to research conducted at The Ohio